<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">grekov</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник хирургии имени И.И. Грекова</journal-title><trans-title-group xml:lang="en"><trans-title>Grekov's Bulletin of Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4625</issn><issn pub-type="epub">2686-7370</issn><publisher><publisher-name>Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/0042-4625-2013-172-5-011-015</article-id><article-id custom-type="elpub" pub-id-type="custom">grekov-648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВОПРОСЫ ОБЩЕЙ НЕОТЛОЖНОЙ ХИРУРГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEMS OF GENERAL AND SPECIAL SURGERY</subject></subj-group></article-categories><title-group><article-title>РЕВАСКУЛЯРИЗАЦИЯ ПОЧЕК И ОТДАЛЁННАЯ СЕРДЕЧНО-СОСУДИСТАЯ ВЫЖИВАЕМОСТЬ БОЛЬНЫХ С АТЕРОСКЛЕРОТИЧЕСКОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК</article-title><trans-title-group xml:lang="en"><trans-title>RENAL REVASCULARIZATION AND LONGTERM CARDIOVASCULAR SURVIVAL OF PATIENTS WITH ATHEROSCLEROTIC RENOVASCULAR DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семёнов</surname><given-names>Дмитрий Владленович</given-names></name><name name-style="western" xml:lang="en"><surname>Semyonov</surname><given-names>D. V.</given-names></name></name-alternatives><email xlink:type="simple">vladlenychspb@mai.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яицкий</surname><given-names>Николай Антонович</given-names></name><name name-style="western" xml:lang="en"><surname>Yaitsky</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добронравов</surname><given-names>Владимир Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Dobronravov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">dobronravov@nephrolog.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Туробова</surname><given-names>Евгения Павловна</given-names></name><name name-style="western" xml:lang="en"><surname>Turobova</surname><given-names>E. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябиков</surname><given-names>Михаил Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabikov</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">kk1kspb@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вахитов</surname><given-names>Карим Мавлетович</given-names></name><name name-style="western" xml:lang="en"><surname>Vakhitov</surname><given-names>K. M.</given-names></name></name-alternatives><email xlink:type="simple">karim.87.spb@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт нефрологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research institute of nephrology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2018</year></pub-date><volume>172</volume><issue>5</issue><fpage>11</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Семёнов Д.В., Яицкий Н.А., Добронравов В.А., Туробова Е.П., Рябиков М.А., Вахитов К.М., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Семёнов Д.В., Яицкий Н.А., Добронравов В.А., Туробова Е.П., Рябиков М.А., Вахитов К.М.</copyright-holder><copyright-holder xml:lang="en">Semyonov D.V., Yaitsky N.A., Dobronravov V.A., Turobova E.P., Ryabikov M.A., Vakhitov K.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vestnik-grekova.ru/jour/article/view/648">https://www.vestnik-grekova.ru/jour/article/view/648</self-uri><trans-abstract xml:lang="en"><p>The prospective investigation of 185 patients (118 men and 67 women in the age of 35–79 years (on the average 60±9 years) with atherosclerotic renovascular disease was carried out. The disease was detected by one- (62%) and two- (38%) hemodynamic value (&gt;50%) of renal artery stenosis. Renal function, arterial pressure, cardiovascular death cases were estimated in 4 groups of patients during the period of 2,5–126 months (on the average 33 months). The patients of the first group (n=103) were undergone the renal revascularization (51 open and 80 endovascular). The patients of the second group (n=20) were after combined open renal revascularization (25) and after performed reconstruction of abdominal aorta and its branches and lower extremities arteries concerning aneurysmatic and occlusive lesions. The patients of the third group (n=19) had only reconstruction of lower extremities arteries concerning their ischemia without renal revascularization. The patients of the fourth group (n=43) haven’t been operated because of the refusal of intervention. The lowest rate of survival was in the fourth group, who used the conservative therapy. Long-term survival didn’t differ after open and endovascular therapy. The Koks regression analysis showed, that the improvement of long-term survival of the patients was associated with renal revascularization [Exp (B)=0,25, p&lt;0,001] and didn’t depend on the method of renal arteries reconstruction. A strategy of careful selection of patients with the application of interdisciplinary approach should be the base of clinical practice in renovascular disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь почек</kwd><kwd>открытая и эндоваскулярная реваскуляризация почек</kwd><kwd>сердечно-сосудистая выживаемость</kwd><kwd>ischemic kidney disease</kwd><kwd>open and endovascular renal revascularization</kwd><kwd>cardiovascular survival</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Игнашов А. М., Смирнов А. В., Добронравов В.Аи др. Ишемическая болезнь почек // Нефрология. 2004. Т. 8, прил. 2. С. 19–27.</mixed-citation><mixed-citation xml:lang="en">Игнашов А. М., Смирнов А. В., Добронравов В.Аи др. Ишемическая болезнь почек // Нефрология. 2004. Т. 8, прил. 2. С. 19–27.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов А. В., Добронравов В. А., Каюков И. Г. Кардиоренальный континуум: основы превентивной терапии // Нефрология. 2005. № 3. С. 7–15.</mixed-citation><mixed-citation xml:lang="en">Смирнов А. В., Добронравов В. А., Каюков И. Г. Кардиоренальный континуум: основы превентивной терапии // Нефрология. 2005. № 3. С. 7–15.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов А. В., Есаян А. М., Каюков И. Г.и др. Современные подходык замедлению прогрессирования хронической болезни почек // Нефрология. 2004. № 3. С. 89–99.</mixed-citation><mixed-citation xml:lang="en">Смирнов А. В., Есаян А. М., Каюков И. Г.и др. Современные подходык замедлению прогрессирования хронической болезни почек // Нефрология. 2004. № 3. С. 89–99.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Семенов Д. В., Смирнов А. В., Кириллова Е. В.и др. Допплерографическая оценка артериального кровотокаи изменения функции почеку больныхс атеросклерозом почечных артерий после реваскуляризации // Нефрология. 2012. № 1. С. 45–51.</mixed-citation><mixed-citation xml:lang="en">Семенов Д. В., Смирнов А. В., Кириллова Е. В.и др. Допплерографическая оценка артериального кровотокаи изменения функции почеку больныхс атеросклерозом почечных артерий после реваскуляризации // Нефрология. 2012. № 1. С. 45–51.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов А. В., Шилов Е. М., Добронравов В. А.и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактикии подходык лечению // Нефрология. 2012. № 1. С. 89–115.</mixed-citation><mixed-citation xml:lang="en">Смирнов А. В., Шилов Е. М., Добронравов В. А.и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактикии подходык лечению // Нефрология. 2012. № 1. С. 89–115.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bax L., Woittiez A. J., Kouwenberg H. J. et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: randomized trial (STAR) // Ann. Intern. Med. 2009. Vol. 150, № 12, 840–848. P. W150–W151.</mixed-citation><mixed-citation xml:lang="en">Bax L., Woittiez A. J., Kouwenberg H. J. et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: randomized trial (STAR) // Ann. Intern. Med. 2009. Vol. 150, № 12, 840–848. P. W150–W151.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Caps M. T., Zierler R. E., Polissar N. L. et al. Risk of atrophy in kidney with atherosclerotic renal artery stenosis // Kidney Int. 1998. Vol. 53. P. 735–742.</mixed-citation><mixed-citation xml:lang="en">Caps M. T., Zierler R. E., Polissar N. L. et al. Risk of atrophy in kidney with atherosclerotic renal artery stenosis // Kidney Int. 1998. Vol. 53. P. 735–742.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Erdoes L. S., Berman S. S., Hunter G. C., Mills J. L. Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularisation // Am. J. Kid. Dis. 1996. Vol. 27, № 4. P. 496–503.</mixed-citation><mixed-citation xml:lang="en">Erdoes L. S., Berman S. S., Hunter G. C., Mills J. L. Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularisation // Am. J. Kid. Dis. 1996. Vol. 27, № 4. P. 496–503.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Go A. S., Chertow G. M., Dongjie Fan M. P.H. et al. Chronic kidney disease and the risk of death, cardiovascular events and hospitalization // N. Engl. Med. J. 2004. Vol. 351, № 13. P. 1296–1305.</mixed-citation><mixed-citation xml:lang="en">Go A. S., Chertow G. M., Dongjie Fan M. P.H. et al. Chronic kidney disease and the risk of death, cardiovascular events and hospitalization // N. Engl. Med. J. 2004. Vol. 351, № 13. P. 1296–1305.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen K. J., Wilson D. B., Dean R. H. Atherosclerotic renovascular disease and ischemic nephrophaty // R. B. Rutherford «Vascular Surgery» 2005, W. B. Saunders company, Fifth Ed., 1805–1824.</mixed-citation><mixed-citation xml:lang="en">Hansen K. J., Wilson D. B., Dean R. H. Atherosclerotic renovascular disease and ischemic nephrophaty // R. B. Rutherford «Vascular Surgery» 2005, W. B. Saunders company, Fifth Ed., 1805–1824.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Herrmann S. M., Textor S. C. Diagnostic criteria for renovascular disease: where are we now? // Nephrol. Dial. Transplant. 2012. Vol. 27, № 7. P. 2657–2663.</mixed-citation><mixed-citation xml:lang="en">Herrmann S. M., Textor S. C. Diagnostic criteria for renovascular disease: where are we now? // Nephrol. Dial. Transplant. 2012. Vol. 27, № 7. P. 2657–2663.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Iantorno M., Pola R., Schinzari F. et al. Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension // Cardiology. 2003. Vol. 100, № 1. P. 114–119.</mixed-citation><mixed-citation xml:lang="en">Iantorno M., Pola R., Schinzari F. et al. Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension // Cardiology. 2003. Vol. 100, № 1. P. 114–119.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lao D., Parasher P. S., Cho K. et al. Atherosclerotic renal artery stenosis — diagnosis and treatment // Mayo Clinic Proc. 2011. Vol. 86, № 7. P. 649–657.</mixed-citation><mixed-citation xml:lang="en">Lao D., Parasher P. S., Cho K. et al. Atherosclerotic renal artery stenosis — diagnosis and treatment // Mayo Clinic Proc. 2011. Vol. 86, № 7. P. 649–657.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Losito A., Errico R., Santirosi P. et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition // Nephr. Dial. Transpl. 2005. Vol. 20, № 8. P. 1604–1609.</mixed-citation><mixed-citation xml:lang="en">Losito A., Errico R., Santirosi P. et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition // Nephr. Dial. Transpl. 2005. Vol. 20, № 8. P. 1604–1609.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">McDowall P., Kalra P. A., O’Donoghue D. J. et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure // Lancet 1998. Vol. 352, № 9128. P. 656.</mixed-citation><mixed-citation xml:lang="en">McDowall P., Kalra P. A., O’Donoghue D. J. et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure // Lancet 1998. Vol. 352, № 9128. P. 656.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">National Kidney Foundation. K/DOKI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification // Am. J. Kid. Dis. 2002. Vol. 39 (suppl.). P. S1–S266.</mixed-citation><mixed-citation xml:lang="en">National Kidney Foundation. K/DOKI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification // Am. J. Kid. Dis. 2002. Vol. 39 (suppl.). P. S1–S266.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wheatley K., Ives N., Gray R. et al. Revascularisation versus medical therapy for renal artery stenosis (ASTRAL) // N. Engl. J. Med. 2009. Vol. 361, № 20. P. 1953–1962.</mixed-citation><mixed-citation xml:lang="en">Wheatley K., Ives N., Gray R. et al. Revascularisation versus medical therapy for renal artery stenosis (ASTRAL) // N. Engl. J. Med. 2009. Vol. 361, № 20. P. 1953–1962.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wright J. R., Shurrab A., Cooper A. et al. Left ventricular morphology and function in patients with atherosclerotic renovascular disease // J. Am. Soc. Nephrology. 2005. Vol. 16, № 19. P. 2746–2753.</mixed-citation><mixed-citation xml:lang="en">Wright J. R., Shurrab A., Cooper A. et al. Left ventricular morphology and function in patients with atherosclerotic renovascular disease // J. Am. Soc. Nephrology. 2005. Vol. 16, № 19. P. 2746–2753.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
